Clinical Trial: To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07061925) titled 'To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis' on June 27.

Brief Summary: A Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter, Dose-finding, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of ALC-2203 in Patients with Acute Bronchitis

Study Start Date: April 23

Study Type: INTERVENTIONAL

Condition: Acute Bronchitis

Intervention: DRUG: ALC-2203-1

This group receives ALC-2203-1 and a placebo matching ALC-2203-AC, administered three times daily for 7 days.

DRUG: ALC-2203-2

This group receives ALC-2203-2 and a placebo matching ALC-2203-AC, admini...